StocksFin Logo
HRMY logo
$HRMY

Harmony Biosciences Holdings, Inc.

HRMY country of incorporation
|
https://www.harmonybiosciences.com
|
Mr. John Charles Jacobs M.B.A.
|
180 employees
NASDAQ | Healthcare | Biotechnology
HRMY reported its Q322 earnings on November 1, 2022 (97 weeks ago).
$117.21M 45.2% vs. Q321 Revenues Q322
80.41% -1.8% vs. Q321 Gross Profit Margin
75.03% 729.7% vs. Q321 Net Profit Margin
55.12M 81.7% vs. Q321 Free Cash Flow Q322
$1.48 970.6% vs. Q321 EPS Q322
Company Card Q322
As reported on November 1, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
S+
Growth calculated YoY
Company Card Q322
As reported on November 1, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
S+
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
117.21M
+9.5%
22.96M
87.94M
+273.7%
$1.48
Q22022
107.03M
+25.5%
18.92M
23.53M
+9.5%
$0.4
Q12022
85.31M
14.72M
21.49M
$0.36
FY2021
305.44M
 55.52M
34.6M
$0.7
Q42021
91.21M
+13%
17.82M
22.71M
+336.1%
$0.39
Q32021
80.73M
+9.4%
14.6M
-9.62M
-168.1%
$-0.17
Q22021
73.82M
+23.7%
12.69M
14.12M
+91.1%
$0.25
Q12021
59.67M
10.41M
7.39M
$0.13
FY2020
159.74M
 27.74M
-36.94M
$-1.43
FY2019
6M
 1.58M
-151.98M
$-3.09
FY2018
0
 0
-39.9M
$-0.81
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
643.46M
 299.58M
261.34M
191.73M
343.88M
Q22022
505.03M
 258.5M
236.53M
191.81M
246.53M
Q12022
464.01M
 249.5M
224.5M
191.9M
214.5M
FY2021
433.44M
 246.94M
234.31M
193.98M
186.51M
FY2020
427.07M
 329.89M
228.63M
194.25M
97.18M
FY2019
106.7M
 118.29M
24.46M
97.95M
-11.59M
FY2018
89.28M
 7.75M
83.52M
0
81.53M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
55.21M
 -32.45M
2.05M
-86k
55.12M
+63.6%
Q22022
33.73M
 -22.45M
750k
-41k
33.69M
+401%
Q12022
28.85M
 -40.05M
1.38M
-40.05M
-11.19M
FY2021
98.56M
 -100.3M
7.42M
-100.3M
-1.74M
FY2020
-2.99M
 -2M
209.16M
-2M
-4.99M
FY2019
-75.44M
 -127.15M
143.77M
-127.15M
-202.59M
FY2018 No data.
Institutional Ownership
Dividend History
No dividend history.
Number of Employees